查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566961

抗菌縫線市場：按類型、最終用戶分類：2024-2033 年全球機會分析與產業預測

Antimicrobial Suture Market By Type (Absorbable, Non absorbable) , By End User (Hospitals, Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

抗菌縫線市場

2023年抗菌縫線市場價值為2.979億美元，預計2024年至2033年複合年成長率為3.7%，到2033年將達到4.301億美元。

抗菌縫合線是滲透對細菌有毒的化合物的醫用縫合線。塗在傷口上可防止細菌生長，減少感染機會。抗菌縫合線所含化學物質的作用機轉是抑制細菌的細胞機轉。縫合線用於各種外科手術中的創傷治療，例如普通外科、心血管外科和整形外科外科。對於感染風險高的患者、免疫系統受損的患者以及接受長時間外科手術的患者來說，縫合至關重要。

人們對傷口和手術部位感染風險的認知不斷提高，正在推動抗菌縫線的採用，從而推動市場成長。此外，由於慢性病盛行率上升、人口快速老化以及醫療設施的迅速增加，外科手術的頻率也在增加。這些因素推動了對抗菌縫線的需求。目前，隨著奈米工程增強抗菌性能，在縫合線製造的應用越來越受到關注。該技術也已用於設計生物分解性的縫合線。

然而，與傳統縫合線相比，抗菌縫合線的成本較高，限制了其採用，特別是在低預算的醫療機構中。此外，一些醫療保健專業人員更喜歡傳統抗菌縫線而不是先進的抗菌縫線，因為他們更熟悉它們，這阻礙了市場開拓。相反，具有增強性能的創新智慧縫合線的開拓預計將為市場帶來新的成長機會。麻省理工學院的工程師設計了一種智慧縫合線，既能保護組織，又能在檢測到發炎時釋放藥物。這種縫線取自動物組織，包裹著水凝膠，其中包含藥物、細胞和感測器，並在需要時釋放治療分子。

按部門審查

抗菌縫線市場按類型、最終用戶和地區細分。按類型分類，市場分為可吸收市場和不可吸收市場。依最終使用者分為醫院、診所和其他。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，預計到 2033 年吸收劑領域將成為最大股東。

從最終用戶來看，醫院細分市場將在 2023 年佔據市場主導地位。

按地區分類，北美地區 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章抗菌縫線市場：依類型

  • 市場概況
  • 吸水性
  • 不可吸收

第5章抗菌縫線市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 診所
  • 其他

第6章抗菌縫線市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國抗菌縫線市場
    • 加拿大抗菌縫線市場
    • 墨西哥抗菌縫線市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國抗菌縫線市場
    • 德國抗菌縫線市場
    • 義大利抗菌縫線市場
    • 西班牙抗菌縫線市場
    • 英國抗菌縫線市場
    • 其他歐洲抗菌縫合線市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國抗菌縫線市場
    • 日本抗菌縫線市場
    • 印度抗菌縫線市場
    • 韓國抗菌縫線市場
    • 澳洲抗菌縫線市場
    • 其他亞太地區抗菌縫合線市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西抗菌縫線市場
    • 南非抗菌縫線市場
    • 沙烏地阿拉伯抗菌縫線市場
    • 其他拉丁美洲/中東/非洲抗菌縫線市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • WL Gore And Associates
  • Medtronic Inc.,
  • Johnson And Johnson
  • Sutures India Pvt Ltd.
  • Lotus Surgicals
  • B. Braun Melsungen AG
  • Smith And Nephew Plc
  • Boston Scientific Corporation
  • Demetech Corporation
  • Conmed Corporation
簡介目錄
Product Code: A324365

Antimicrobial Suture Market

The antimicrobial suture market was valued at $297.9 million in 2023 and is projected to reach $430.1 million by 2033, growing at a CAGR of 3.7% from 2024 to 2033.

An antimicrobial suture is a medical stitch macerated with chemical compounds which are toxic to bacteria. It is applied on wounds to prevent the growth of bacteria and reduce the chances of infection. The action mechanism of the chemical compound present in antimicrobial sutures involves interrupting the cell mechanisms of bacteria. Different surgical procedures such as general surgeries, cardiovascular surgeries, and orthopedic surgeries involve the application of sutures for wound healing. The sutures are essential for patients with high risk of infection, with compromised immune systems, or those undergoing lengthy surgical procedures.

Increase in awareness about the risk of infection over wounds or surgical sites is enhancing the adoption of antimicrobial sutures, thereby driving the growth of the market. In addition, the frequency of surgical procedures is increasing due to rise in prevalence of chronic diseases, exponential growth of aging population, and upsurge in the availability of medical facilities. These factors are boosting the demand for antimicrobial sutures. Currently, the usage of nanoengineering in the production of sutures is acquiring traction as the technique enhances their antimicrobial properties. The technique is further being utilized to design biodegradable sutures.

However, the higher cost of antimicrobial sutures as compared to the conventional stitches restricts their adoption, particularly in the healthcare settings with low budgets. In addition, several healthcare providers prefer conventional sutures over the advanced antimicrobial sutures due to the familiarity with its application, hence restraining the development of the market. On the contrary, the development of innovative smart sutures with enhanced attributes is anticipated to present novel growth opportunities for the market. Engineers from the Massachusetts Institute of Technology have designed a smart suture which releases drugs upon the detection of inflammation, along with holding the tissue in place. Derived from animal tissues, the suture encloses hydrogel integrated with drugs, cells, or sensors, which release the therapeutic molecules when necessary.

Segment Review

The antimicrobial suture market is segmented into type, end user, and region. On the basis of type, the market is bifurcated into absorbable and non-absorbable. As per end user, it is divided into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the absorbable segment is expected to be the highest shareholder by 2033.

As per end user, the hospital segment dominated the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global antimicrobial suture market include W.L. Gore & Associates, Medtronic Inc., Johnson and Johnson, Sutures India Pvt Ltd., Lotus Surgicals, B. Braun Melsungen AG, Smith & Nephew plc, Boston Scientific Corporation, Demetech Corporation, and Conmed Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Type

  • Absorbable
  • Non absorbable

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • W.L. Gore & Associates
    • Medtronic Inc.,
    • Johnson and Johnson
    • Sutures India Pvt Ltd.
    • Lotus Surgicals
    • B. Braun Melsungen AG
    • Smith & Nephew plc
    • Boston Scientific Corporation
    • Demetech Corporation
    • Conmed Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANTIMICROBIAL SUTURE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Absorbable
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non Absorbable
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANTIMICROBIAL SUTURE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANTIMICROBIAL SUTURE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Antimicrobial Suture Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Antimicrobial Suture Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Antimicrobial Suture Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Antimicrobial Suture Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Antimicrobial Suture Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Antimicrobial Suture Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Antimicrobial Suture Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Antimicrobial Suture Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Antimicrobial Suture Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Antimicrobial Suture Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Antimicrobial Suture Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Antimicrobial Suture Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Antimicrobial Suture Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Antimicrobial Suture Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Antimicrobial Suture Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Antimicrobial Suture Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Antimicrobial Suture Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Antimicrobial Suture Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Antimicrobial Suture Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. W.L. Gore And Associates
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Medtronic Inc.,
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Johnson And Johnson
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Sutures India Pvt Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Lotus Surgicals
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. B. Braun Melsungen AG
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Smith And Nephew Plc
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Boston Scientific Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Demetech Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Conmed Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments